Gilteritinib vs salvage chemotherapy in FLT3-mutated acute myeloid leukemia: number needed to treat for clinical outcomes per a secondary analysis of the ADMIRAL trial. Zeidan AM, Qi CZ, Yang H, Garnham A, et al. Leuk Lymphoma 2021 Nov 8:1-3. doi: 10.1080/10428194.2021.2001467.

Read + Share

Amedeo Smart

Independent Medical Education